1Francesco Montagnani,Gina Turrisi,Claudio Marinozzi,Camillo Aliberti,Giammaria Fiorentini.Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis[J]. Gastric Cancer . 2011 (1)
2Y. S. Hong,S. Y. Song,S. I. Lee,H. C. Chung,S. H. Choi,S. H. Noh,J. N. Park,J. Y. Han,J. H. Kang,K. S. Lee,J. Y. Cho.A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer[].Annals of Oncology.2004
3Louvet C,Andre T,Tigaud J M,et al.PhaseⅡ study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. Journal of Clinical Oncology . 2002
4Thuss-Patience PC,Kretzschmar A,Dogan Y,et al.Capecitabine and docetaxel for advanced gastric cancer. Journal of Clinical Oncology . 2006
5De Vita F,Orditura M,Matano E,et al.A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. British Journal of Cancer . 2005
6Kondo K,Chin K, et al.A multicenter phase II trial using 4-week cycles of capecitabine in advanced/metastatic gastric cancer (AGC). Proceedings of the American Society of Clinical Oncology . 2003
3LEE J, PARK CK, PARK JO, et al. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy[ J]. Clin Cancer Res, 2008,14 ( 1 ) : 82-88.
4MONRERO E, ABREU C, TONINO P, et al. Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas [ J ]. J Cancer Res Clin Oncol, 2008, 134(2) :193-201.
5LIN S Z, TONG H F, YOU T, et al. Palliative gastrectomy and chemotherapy for stage IV gastric cancer [ J ]. J Cancer Res Clin Oncol, 2008, 134(2) :187-192.
6ROTH A D, FAZIO N, STUPP R, et al. Docetaxel, cisplatin,and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research[ J]. J Clin Oncol, 2007, 25 (22):3217- 3223.
7CHIESA MD, BUTI S, TOMASELLO G, et al. A pilot phase Ⅱ study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer[ J]. Tumor, 2007, 93 ( 3 ) :244-247.
8M ARUTA F, ISHIZONE S, HIRAGURI M,et al. A clinical study of docetaxel with or without 5' DFUR as a second-line chemotherapy for advanced gastric cancer [ J ]. Med Oncol, 2007, 24 ( 1 ) : 71- 75.
9NERI B, PANTALEO P, GIOMMONI E, et al. Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase Ⅱ study [ J]. Br J Cancer, 2007, 96(7 ) : 1043-1046.
10KIM D , JOO J K, RYU SY, et al. Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia [ J ]. Dig Surg, 2006, 23(5-6):313-318.
